Radermacher J, Klanke B, Schurek H J, Stolte H F, Frölich J C
Department of Clinical Pharmacology, Hannover Medical School, Germany.
Kidney Int. 1992 Jun;41(6):1549-59. doi: 10.1038/ki.1992.225.
The effect of the addition of N omega-nitro-L-arginine (L-NNA, 10 and 100 microM) to isolated rat kidneys perfused with a complex medium containing 21 amino acids has been studied. A cyclooxygenase inhibitor was added throughout to block prostaglandin synthesis. L-NNA caused significant reductions in renal perfusion flow rate (PFR, 9.8 +/- 1.4 vs. 15.9 +/- 1.1 ml.min-1.g kidney wt-1, P less than 0.0001), glomerular filtration rate (GFR, 566 +/- 57 vs. 705 +/- 47 microliters.min-1.g kidney wt-1, P less than 0.05) and an increase in the relative filtration fraction (%FF, 7.0 +/- 0.6 vs. 5.2 +/- 0.4%, P less than 0.05) compared to control kidneys. L-NNA perfused kidneys had a lower absolute sodium (72 +/- 9 vs. 88 +/- 4 mumol.min-1.g kidney wt-1, P less than 0.05) and glucose reabsorption (3.5 +/- 0.5 vs. 5.4 +/- 0.4 mumol.min-1.g kidney wt-1, P less than 0.05), corresponding mainly to a lower sodium and glucose filtration. However, the relative reabsorption of sodium and glucose in the presence of L-NNA was attenuated, too (82.8 +/- 2.0 vs. 87.0 +/- 3.3% P less than 0.05 and 91.3 +/- 1.1 vs. 94.1 +/- 0.5%, P less than 0.05). Potassium handling and protein excretion were not changed significantly; fractional protein excretion increased slightly with the addition of L-arginine (47 +/- 5 vs. 55 +/- 7 ng.microliters-1, P less than 0.05). The differences between control and L-NNA treated kidneys (with the exception of differences in FRGluc) could be fully (L-NNA, 10 microM) or partially (L-NNA 100 microns) reversed by adding L-arginine (1 mM) to the perfusion medium. The observed results could be obtained in two different rat strains (Sprague-Dawley and Wistar). Only L-NNA and L-arginine caused the observed changes, while D-NNA and D-arginine were without effect. It is concluded that NO/EDRF is basally released from the isolated perfused rat kidney, and is of importance not only in the regulation of renal hemodynamics but also in the regulation of renal tubular function.
研究了向灌注含21种氨基酸的复合培养基的离体大鼠肾脏中添加Nω-硝基-L-精氨酸(L-NNA,10和100μM)的效果。全程添加环氧化酶抑制剂以阻断前列腺素合成。L-NNA导致肾灌注流速(PFR,9.8±1.4对15.9±1.1ml·min-1·g肾重-1,P<0.0001)、肾小球滤过率(GFR,566±57对705±47μl·min-1·g肾重-1,P<0.05)显著降低,相对滤过分数增加(%FF,7.0±0.6对5.2±0.4%,P<0.05),与对照肾脏相比。灌注L-NNA的肾脏绝对钠重吸收(72±9对88±4μmol·min-1·g肾重-1,P<0.05)和葡萄糖重吸收较低(3.5±0.5对5.4±0.4μmol·min-1·g肾重-1,P<0.05),主要对应于较低的钠和葡萄糖滤过。然而,L-NNA存在时钠和葡萄糖的相对重吸收也减弱(82.8±2.0对87.0±3.3%,P<0.05和91.3±1.1对94.1±0.5%,P<0.05)。钾的处理和蛋白质排泄无显著变化;添加L-精氨酸后蛋白质排泄分数略有增加(47±5对55±7ng·μl-1,P<0.05)。对照肾脏和L-NNA处理的肾脏之间的差异(除FRGluc差异外)通过向灌注培养基中添加L-精氨酸(1mM)可完全(L-NNA,10μM)或部分(L-NNA 100μM)逆转。在两种不同的大鼠品系(Sprague-Dawley和Wistar)中均可获得观察结果。只有L-NNA和L-精氨酸引起观察到的变化,而D-NNA和D-精氨酸无作用。结论是,NO/EDRF从离体灌注的大鼠肾脏中基础释放,不仅在肾血流动力学调节中起重要作用,而且在肾小管功能调节中也起重要作用。